Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $9.67 trillion, total revenue of $4.62 trillion and a weighted average PE ratio of 51.93.
Market Cap
9.67T
Revenue
4.62T
Profits
186.25B
PE Ratio
51.93
Profit Margin
4.03%
Dividend Yield
0.38%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.15T | 0.50% | 2,061,434 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 652.48B | 0.86% | 6,398,165 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 505.38B | -0.14% | 3,110,708 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 365.41B | -0.80% | 3,900,164 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 347.70B | -0.63% | 8,238,388 | 66.57B |
| 6 | NVS | Novartis AG | 294.21B | -0.50% | 1,945,319 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 263.52B | -0.34% | 1,698,109 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 260.36B | 1.61% | 1,647,852 | 47.35B |
| 9 | AMGN | Amgen Inc. | 244.27B | 0.87% | 2,908,782 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 197.40B | 0.08% | 5,002,313 | 30.46B |
| 11 | ABT | Abbott Laboratories | 177.61B | -0.45% | 5,479,930 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 168.22B | -0.98% | 11,358,982 | 50.34B |
| 13 | PFE | Pfizer Inc. | 167.86B | -1.17% | 27,253,637 | 63.70B |
| 14 | DHR | Danaher Corporation | 164.68B | 0.89% | 3,139,550 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 153.97B | -0.38% | 1,845,096 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 134.26B | 1.66% | 1,283,773 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 123.73B | -1.59% | 7,412,615 | 49.19B |
| 18 | SYK | Stryker Corporation | 116.61B | 0.86% | 2,325,667 | 25.84B |
| 19 | MDT | Medtronic plc | 116.02B | 0.88% | 9,579,105 | 37.54B |
| 20 | CVS | CVS Health Corporation | 115.04B | -1.29% | 5,578,357 | 412.65B |
| 21 | MCK | McKesson Corporation | 111.99B | -0.67% | 764,138 | 410.98B |
| 22 | SNY | Sanofi | 100.83B | 0.84% | 2,910,569 | 55.89B |
| 23 | HCA | HCA Healthcare, Inc. | 100.29B | 2.95% | 2,131,480 | 78.70B |
| 24 | GSK | GSK plc | 97.74B | -4.32% | 8,116,152 | 44.53B |
| 25 | ELV | Elevance Health, Inc. | 89.54B | -1.68% | 1,191,267 | 201.83B |
| 26 | MRNA | Moderna, Inc. | 85.50B | 2.98% | 11,974,020 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 81.21B | -0.35% | 536,200 | 15.53B |
| 28 | CI | The Cigna Group | 77.95B | -1.10% | 1,024,098 | 282.38B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 63.65B | -0.59% | 3,122,059 | 28.42B |
| 30 | COR | Cencora, Inc. | 61.89B | -0.31% | 1,076,740 | 332.77B |
| 31 | BSX | Boston Scientific Corporation | 61.49B | -5.84% | 69,877,062 | 21.07B |
| 32 | NTRA | Natera, Inc. | 61.16B | 3.27% | 1,383,379 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 56.68B | -0.69% | 1,102,296 | 254.25B |
| 34 | ARGX | argenx SE | 55.53B | 1.05% | 193,362 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 53.16B | 0.07% | 1,740,469 | 22.48B |
| 36 | EW | Edwards Lifesciences Corporation | 52.90B | 1.06% | 2,296,574 | 6.51B |
| 37 | VEEV | Veeva Systems Inc. | 51.46B | 1.39% | 1,399,464 | 3.46B |
| 38 | A | Agilent Technologies, Inc. | 51.16B | 2.25% | 1,550,483 | 7.37B |
| 39 | HUM | Humana Inc. | 49.46B | -0.72% | 1,046,531 | 145.68B |
| 40 | WAT | Waters Corporation | 46.85B | 1.78% | 872,592 | 4.64B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 46.58B | -1.04% | 4,647,437 | 17.32B |
| 42 | IQV | IQVIA Holdings Inc. | 45.99B | 2.76% | 1,722,532 | 17.31B |
| 43 | IDXX | IDEXX Laboratories, Inc. | 44.35B | 0.30% | 350,343 | 4.55B |
| 44 | HLN | Haleon plc | 43.85B | -0.79% | 22,189,962 | 14.80B |
| 45 | ILMN | Illumina, Inc. | 43.61B | 3.33% | 2,239,437 | 4.49B |
| 46 | MDLN | Medline Inc. | 42.56B | -0.03% | 8,486,013 | 29.94B |
| 47 | ONC | BeOne Medicines AG | 42.45B | 1.99% | 274,916 | 6.13B |
| 48 | RVMD | Revolution Medicines, Inc. | 40.45B | 1.34% | 888,269 | - |
| 49 | RPRX | Royalty Pharma plc | 37.27B | -0.70% | 2,414,519 | 2.54B |
| 50 | BIIB | Biogen Inc. | 36.08B | -3.43% | 2,492,779 | 10.30B |
| 51 | RMD | ResMed Inc. | 35.18B | -0.25% | 1,020,366 | 5.65B |
| 52 | GMAB | Genmab A/S | 34.47B | 28.25% | 29,283,081 | 4.13B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 34.28B | 6.62% | 9,567,477 | 21.64B |
| 54 | MTD | Mettler-Toledo International Inc. | 34.03B | 0.78% | 179,646 | 4.13B |
| 55 | ALC | Alcon Inc. | 33.59B | 0.59% | 1,087,130 | 10.86B |
| 56 | CNC | Centene Corporation | 33.19B | -2.42% | 5,998,798 | 180.41B |
| 57 | ZTS | Zoetis Inc. | 32.15B | -0.55% | 2,618,162 | 9.53B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.10B | 2.47% | 1,943,915 | 4.80B |
| 59 | DXCM | DexCom, Inc. | 29.67B | 0.08% | 5,370,283 | 4.97B |
| 60 | LH | Labcorp Holdings Inc. | 29.25B | 8.78% | 1,797,133 | 14.59B |
| 61 | WST | West Pharmaceutical Services, Inc. | 28.41B | 1.34% | 773,260 | 3.33B |
| 62 | DGX | Quest Diagnostics Incorporated | 27.02B | 1.26% | 932,792 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 26.81B | 1.56% | 5,773,657 | 7.53M |
| 64 | PHG | Koninklijke Philips N.V. | 26.41B | 2.35% | 1,116,588 | 20.18B |
| 65 | UTHR | United Therapeutics Corporation | 25.15B | -0.80% | 421,649 | 3.15B |
| 66 | GH | Guardant Health, Inc. | 24.50B | 2.54% | 2,320,912 | 1.18B |
| 67 | INCY | Incyte Corporation | 23.69B | 0.23% | 1,808,347 | 5.82B |
| 68 | STE | STERIS plc | 22.31B | 0.13% | 417,311 | 6.04B |
| 69 | BNTX | BioNTech SE | 22.10B | 1.07% | 869,406 | 3.03B |
| 70 | THC | Tenet Healthcare Corporation | 21.62B | 2.46% | 1,090,304 | 21.81B |
| 71 | VTRS | Viatris Inc. | 21.56B | 0.27% | 7,851,090 | 14.74B |
| 72 | INSM | Insmed Incorporated | 21.18B | 2.13% | 4,648,166 | 1.14B |
| 73 | MEDP | Medpace Holdings, Inc. | 19.38B | 2.80% | 299,629 | 2.84B |
| 74 | RVTY | Revvity, Inc. | 18.45B | 2.14% | 2,178,621 | 2.91B |
| 75 | ZBH | Zimmer Biomet Holdings, Inc. | 18.39B | 0.34% | 2,169,889 | 8.51B |
| 76 | CRL | Charles River Laboratories International, Inc. | 17.85B | 4.22% | 1,299,379 | 4.00B |
| 77 | EXEL | Exelixis, Inc. | 16.42B | 1.42% | 1,640,435 | 2.44B |
| 78 | ASND | Ascendis Pharma A/S | 16.39B | 1.50% | 660,187 | 1.20B |
| 79 | ICLR | ICON Public Limited Company | 16.04B | 17.04% | 3,947,574 | 8.28B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.79B | -0.32% | 1,081,246 | 3.37B |
| 81 | HALO | Halozyme Therapeutics, Inc. | 14.76B | 1.19% | 1,337,151 | 1.66B |
| 82 | SOLV | Solventum Corporation | 13.93B | -1.36% | 1,565,370 | 8.31B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 13.84B | 2.09% | 3,111,377 | 713.07M |
| 84 | TEM | Tempus AI, Inc. | 13.82B | 6.18% | 6,920,821 | 1.43B |
| 85 | JAZZ | Jazz Pharmaceuticals plc | 13.31B | -0.83% | 816,104 | 4.60B |
| 86 | BAX | Baxter International Inc. | 13.16B | 2.17% | 12,433,624 | 11.47B |
| 87 | SMMT | Summit Therapeutics Inc. | 12.61B | 2.87% | 3,316,818 | - |
| 88 | PEN | Penumbra, Inc. | 12.54B | -1.77% | 851,285 | 1.50B |
| 89 | SNN | Smith & Nephew plc | 12.47B | 0.07% | 1,050,130 | 6.30B |
| 90 | BTSG | BrightSpring Health Services, Inc. | 12.39B | 1.88% | 1,880,176 | 14.37B |
| 91 | EHC | Encompass Health Corporation | 12.04B | 0.46% | 1,007,907 | 6.34B |
| 92 | FMS | Fresenius Medical Care AG | 11.99B | 0.53% | 803,022 | 22.19B |
| 93 | DVA | DaVita Inc. | 11.73B | 1.23% | 439,255 | 14.01B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.68B | 2.91% | 4,468,801 | 3.44B |
| 95 | TECH | Bio-Techne Corporation | 11.40B | 0.12% | 2,720,483 | 1.22B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.32B | - | 4,394,096 | 5.02B |
| 97 | COO | The Cooper Companies, Inc. | 11.30B | -0.78% | 4,243,318 | 4.24B |
| 98 | AVTR | Avantor, Inc. | 11.29B | -2.57% | 29,719,216 | 6.64B |
| 99 | ALGN | Align Technology, Inc. | 10.91B | 1.10% | 1,301,220 | 4.16B |
| 100 | GMED | Globus Medical, Inc. | 10.91B | 0.44% | 772,415 | 3.14B |
| 101 | TXG | 10x Genomics, Inc. | 10.89B | 7.18% | 5,047,425 | 616.91M |
| 102 | TWST | Twist Bioscience Corporation | 10.88B | 8.51% | 3,483,465 | 431.80M |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 10.84B | 1.17% | 2,001,308 | 3.41B |
| 104 | GKOS | Glaukos Corporation | 10.70B | 0.14% | 1,884,260 | 690.33M |
| 105 | ENSG | The Ensign Group, Inc. | 10.65B | 8.62% | 974,014 | 5.67B |
| 106 | RGEN | Repligen Corporation | 10.47B | 5.06% | 1,448,254 | 805.61M |
| 107 | QGEN | Qiagen N.V. | 10.41B | 0.32% | 4,534,884 | 2.10B |
| 108 | PODD | Insulet Corporation | 10.33B | -0.60% | 1,034,617 | 3.05B |
| 109 | MOH | Molina Healthcare, Inc. | 10.32B | -0.68% | 543,860 | 42.08B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 10.30B | 1.08% | 251,320 | 2.59B |
| 111 | KYMR | Kymera Therapeutics, Inc. | 10.19B | 4.20% | 768,077 | 105.00M |
| 112 | UHS | Universal Health Services, Inc. | 10.15B | -2.90% | 1,510,061 | 18.35B |
| 113 | CAI | Caris Life Sciences, Inc. | 10.02B | 5.29% | 4,250,445 | 989.61M |
| 114 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.96B | -2.12% | 296,021 | 1.28B |
| 115 | PCVX | Vaxcyte, Inc. | 9.67B | 1.30% | 2,212,720 | - |
| 116 | KRYS | Krystal Biotech, Inc. | 9.51B | 0.26% | 199,745 | 440.48M |
| 117 | HSIC | Henry Schein, Inc. | 9.47B | 0.84% | 934,462 | 13.60B |
| 118 | BRKR | Bruker Corporation | 9.45B | 2.07% | 2,990,657 | 3.50B |
| 119 | OSCR | Oscar Health, Inc. | 9.40B | -2.78% | 4,151,241 | 15.32B |
| 120 | IBRX | ImmunityBio, Inc. | 9.34B | 2.09% | 7,166,194 | 165.79M |
| 121 | CORT | Corcept Therapeutics Incorporated | 9.33B | -1.50% | 1,048,013 | 830.81M |
| 122 | SYRE | Spyre Therapeutics, Inc. | 9.32B | 0.71% | 724,412 | - |
| 123 | HNGE | Hinge Health, Inc. | 9.30B | 1.21% | 873,077 | 720.06M |
| 124 | PTGX | Protagonist Therapeutics, Inc. | 9.20B | 0.72% | 318,425 | 281.99M |
| 125 | CYTK | Cytokinetics, Incorporated | 8.52B | -0.39% | 1,274,147 | 67.67M |
| 126 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.50B | 2.00% | 1,248,403 | 669.50M |
| 127 | HQY | HealthEquity, Inc. | 8.38B | 0.46% | 632,992 | 1.36B |
| 128 | TGTX | TG Therapeutics, Inc. | 8.14B | 1.70% | 933,654 | 799.54M |
| 129 | ATR | AptarGroup, Inc. | 8.09B | 0.52% | 449,259 | 3.93B |
| 130 | PRAX | Praxis Precision Medicines, Inc. | 7.97B | 6.69% | 335,972 | 7.46M |
| 131 | ABVX | ABIVAX Société Anonyme | 7.85B | 3.26% | 536,766 | 5.33M |
| 132 | PACS | PACS Group, Inc. | 7.77B | 2.53% | 762,127 | 5.55B |
| 133 | ALKS | Alkermes plc | 7.59B | 2.10% | 1,439,599 | 1.67B |
| 134 | AXSM | Axsome Therapeutics, Inc. | 7.52B | 0.92% | 739,319 | 776.57M |
| 135 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.48B | 6.70% | 1,706,512 | 945.96M |
| 136 | IONS | Ionis Pharmaceuticals, Inc. | 7.46B | 2.14% | 1,724,241 | 874.09M |
| 137 | AMRX | Amneal Pharmaceuticals, Inc. | 7.36B | -1.40% | 3,309,718 | 3.12B |
| 138 | BLCO | Bausch + Lomb Corporation | 7.29B | 15.78% | 4,106,235 | 5.42B |
| 139 | GRFS | Grifols, S.A. | 7.15B | 0.25% | 969,082 | 8.48B |
| 140 | GRAL | GRAIL, Inc. | 7.05B | 4.83% | 1,151,071 | 165.26M |
| 141 | CHE | Chemed Corporation | 6.94B | 4.77% | 325,177 | 2.66B |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.84B | 5.01% | 12,275,267 | 2.58B |
| 143 | IOVA | Iovance Biotherapeutics, Inc. | 6.71B | 1.58% | 9,706,338 | 324.97M |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.53B | -0.05% | 1,375,675 | 1.56B |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.36B | 2.26% | 268,227 | 290.54M |
| 146 | ORKA | Oruka Therapeutics, Inc. | 6.35B | 0.17% | 793,789 | - |
| 147 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.33B | -0.23% | 533,870 | 239.92M |
| 148 | DOCS | Doximity, Inc. | 6.10B | 3.04% | 1,995,625 | 655.57M |
| 149 | KOD | Kodiak Sciences Inc. | 6.09B | 6.26% | 976,251 | - |
| 150 | IMVT | Immunovant, Inc. | 6.08B | 1.87% | 1,242,505 | - |
| 151 | MANE | Veradermics, Incorporated | 6.01B | 2.21% | 397,384 | - |
| 152 | BLTE | Belite Bio, Inc | 5.99B | 2.06% | 81,860 | - |
| 153 | TFX | Teleflex Incorporated | 5.89B | -0.01% | 630,141 | 2.25B |
| 154 | RDNT | RadNet, Inc. | 5.79B | - | 633,160 | 2.27B |
| 155 | CGON | CG Oncology, Inc. | 5.67B | 1.62% | 944,190 | 6.23M |
| 156 | COGT | Cogent Biosciences, Inc. | 5.59B | 0.69% | 1,748,037 | - |
| 157 | MIRM | Mirum Pharmaceuticals, Inc. | 5.57B | 0.29% | 551,635 | 618.07M |
| 158 | WAY | Waystar Holding Corp. | 5.55B | 3.21% | 1,446,965 | 1.21B |
| 159 | MMSI | Merit Medical Systems, Inc. | 5.51B | -1.41% | 541,434 | 1.58B |
| 160 | MMED | MiniMed Group, Inc. | 5.40B | 1.48% | 10,192,772 | 3.22B |
| 161 | HAE | Haemonetics Corporation | 5.38B | -1.38% | 501,820 | 1.35B |
| 162 | BLLN | BillionToOne, Inc. | 5.38B | -0.06% | 453,411 | 397.41M |
| 163 | SHC | Sotera Health Company | 5.32B | 0.87% | 2,154,304 | 1.22B |
| 164 | STVN | Stevanato Group S.p.A. | 5.31B | -1.07% | 277,603 | 1.40B |
| 165 | ERAS | Erasca, Inc. | 5.29B | -0.66% | 3,412,302 | - |
| 166 | SRRK | Scholar Rock Holding Corporation | 5.27B | 1.79% | 1,673,012 | - |
| 167 | PTCT | PTC Therapeutics, Inc. | 5.26B | 1.50% | 909,250 | 1.01B |
| 168 | CRSP | CRISPR Therapeutics AG | 5.23B | 5.13% | 1,134,647 | 13.39M |
| 169 | CON | Concentra Group Holdings Parent, Inc. | 5.18B | 1.48% | 779,144 | 2.29B |
| 170 | HTFL | HeartFlow, Inc. | 5.14B | 2.21% | 1,643,875 | 212.07M |
| 171 | DFTX | Definium Therapeutics, Inc. | 5.12B | 2.75% | 1,677,853 | - |
| 172 | LFST | LifeStance Health Group, Inc. | 5.12B | 2.21% | 4,274,567 | 1.58B |
| 173 | TVTX | Travere Therapeutics, Inc. | 4.79B | -0.07% | 1,572,944 | 591.33M |
| 174 | OPCH | Option Care Health, Inc. | 4.69B | - | 2,813,165 | 5.69B |
| 175 | DNTH | Dianthus Therapeutics, Inc. | 4.60B | 3.51% | 658,435 | 1.90M |
| 176 | ADPT | Adaptive Biotechnologies Corporation | 4.53B | 2.57% | 2,317,422 | 308.08M |
| 177 | LIVN | LivaNova PLC | 4.44B | 0.35% | 550,582 | 1.47B |
| 178 | ABCL | AbCellera Biologics Inc. | 4.42B | 6.31% | 3,058,614 | 66.17M |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 4.40B | 2.43% | 1,633,331 | - |
| 180 | LEGN | Legend Biotech Corporation | 4.37B | 4.50% | 2,364,653 | 1.27B |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.31B | 4.51% | 2,807,721 | 10.35M |
| 182 | ITGR | Integer Holdings Corporation | 4.30B | -0.15% | 1,020,398 | 1.84B |
| 183 | ICUI | ICU Medical, Inc. | 4.16B | 1.95% | 156,324 | 2.16B |
| 184 | INDV | Indivior Pharmaceuticals, Inc. | 4.10B | 0.14% | 1,530,256 | 1.33B |
| 185 | LQDA | Liquidia Corporation | 4.09B | 0.62% | 2,258,688 | 450.91M |
| 186 | IRTC | iRhythm Holdings, Inc. | 4.09B | 0.19% | 629,204 | 825.34M |
| 187 | VCYT | Veracyte, Inc. | 4.04B | 0.06% | 1,399,290 | 561.90M |
| 188 | ARQT | Arcutis Biotherapeutics, Inc. | 3.95B | -0.73% | 1,669,230 | 463.98M |
| 189 | NVST | Envista Holdings Corporation | 3.85B | 1.53% | 3,188,396 | 2.86B |
| 190 | PLSE | Pulse Biosciences, Inc. | 3.83B | 0.88% | 279,992 | 1.19M |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.75B | -2.88% | 3,309,876 | 53.81M |
| 192 | CDNA | CareDx, Inc. | 3.73B | 2.27% | 907,801 | 458.09M |
| 193 | IRON | Disc Medicine, Inc. | 3.69B | 4.13% | 1,100,511 | - |
| 194 | OGN | Organon & Co. | 3.62B | 0.22% | 3,162,985 | 6.13B |
| 195 | RGC | Regencell Bioscience Holdings Limited | 3.61B | -2.55% | 171,706 | - |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.52B | -0.81% | 1,065,514 | -665.00K |
| 197 | XENE | Xenon Pharmaceuticals Inc. | 3.52B | 0.92% | 2,131,150 | 7.50M |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.50B | 0.74% | 1,336,006 | 1.14B |
| 199 | PBLS | Parabilis Medicines, Inc. | 3.48B | 6.26% | 1,388,213 | 148.00K |
| 200 | CELC | Celcuity Inc. | 3.40B | 2.04% | 1,129,151 | - |
| 201 | NHC | National HealthCare Corporation | 3.32B | -0.01% | 263,653 | 1.56B |
| 202 | ELVN | Enliven Therapeutics, Inc. | 3.28B | 2.49% | 1,261,396 | - |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 3.28B | 1.37% | 994,243 | 234.13M |
| 204 | DYN | Dyne Therapeutics, Inc. | 3.17B | 0.24% | 2,178,086 | - |
| 205 | TARS | Tarsus Pharmaceuticals, Inc. | 3.16B | 1.82% | 400,069 | 606.33M |
| 206 | ATRC | AtriCure, Inc. | 3.12B | -0.15% | 647,548 | 569.62M |
| 207 | TLX | Telix Pharmaceuticals Limited | 3.12B | 2.55% | 244,616 | 890.79M |
| 208 | DNLI | Denali Therapeutics Inc. | 3.08B | 0.36% | 1,586,168 | 3.60M |
| 209 | WRBY | Warby Parker Inc. | 3.02B | -2.55% | 2,085,363 | 911.61M |
| 210 | SGRY | Surgery Partners, Inc. | 3.01B | -0.51% | 3,105,468 | 3.37B |
| 211 | NRIX | Nurix Therapeutics, Inc. | 2.98B | 2.10% | 1,889,609 | 701.94M |
| 212 | VKTX | Viking Therapeutics, Inc. | 2.96B | 1.89% | 4,216,910 | - |
| 213 | AXGN | Axogen, Inc. | 2.89B | 31.47% | 9,288,486 | 251.17M |
| 214 | BEAM | Beam Therapeutics Inc. | 2.88B | 15.58% | 5,007,870 | 156.04M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.85B | 2.83% | 1,204,521 | 2.60B |
| 216 | PRVA | Privia Health Group, Inc. | 2.79B | 0.05% | 649,781 | 2.36B |
| 217 | VRDN | Viridian Therapeutics, Inc. | 2.75B | 0.75% | 1,412,637 | 71.13M |
| 218 | ACHC | Acadia Healthcare Company, Inc. | 2.75B | -1.30% | 2,188,827 | 3.37B |
| 219 | NEOG | Neogen Corporation | 2.65B | -2.81% | 3,597,023 | 884.00M |
| 220 | RCUS | Arcus Biosciences, Inc. | 2.64B | 1.38% | 2,018,620 | 117.00M |
| 221 | MBX | MBX Biosciences, Inc. | 2.61B | 2.25% | 257,112 | - |
| 222 | RXRX | Recursion Pharmaceuticals, Inc. | 2.60B | 7.41% | 28,496,834 | 54.86M |
| 223 | BHC | Bausch Health Companies Inc. | 2.59B | 9.67% | 8,071,564 | 10.85B |
| 224 | ZLAB | Zai Lab Limited | 2.59B | -2.29% | 702,659 | 449.61M |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.55B | 1.95% | 235,451 | 1.46B |
| 226 | CLOV | Clover Health Investments, Corp. | 2.54B | 3.46% | 2,931,857 | 2.48B |
| 227 | ADMA | ADMA Biologics, Inc. | 2.53B | 0.98% | 2,664,910 | 512.28M |
| 228 | NAMS | NewAmsterdam Pharma Company N.V. | 2.52B | 2.78% | 1,433,003 | 7.12M |
| 229 | FTRE | Fortrea Holdings Inc. | 2.46B | 5.94% | 3,591,126 | 2.68B |
| 230 | SUPN | Supernus Pharmaceuticals, Inc. | 2.39B | 0.29% | 1,099,064 | 830.44M |
| 231 | BKD | Brookdale Senior Living Inc. | 2.38B | 4.72% | 5,355,841 | 2.93B |
| 232 | HCM | HUTCHMED (China) Limited | 2.38B | -3.48% | 37,381 | 549.12M |
| 233 | ALMR | Alamar Biosciences, Inc. | 2.38B | 7.42% | 1,109,129 | 100.42M |
| 234 | BHVN | Biohaven Ltd. | 2.34B | 1.50% | 3,149,232 | - |
| 235 | CLDX | Celldex Therapeutics, Inc. | 2.33B | -1.63% | 899,157 | 158.00K |
| 236 | TMDX | TransMedics Group, Inc. | 2.32B | -4.06% | 1,183,591 | 668.47M |
| 237 | NEO | NeoGenomics, Inc. | 2.31B | 4.17% | 2,566,344 | 766.30M |
| 238 | AUPH | Aurinia Pharmaceuticals Inc. | 2.31B | 0.64% | 625,968 | 311.51M |
| 239 | SDGR | Schrödinger, Inc. | 2.31B | 15.53% | 3,316,534 | 259.04M |
| 240 | PHVS | Pharvaris N.V. | 2.30B | 2.72% | 381,027 | - |
| 241 | MD | Pediatrix Medical Group, Inc. | 2.29B | 0.24% | 656,643 | 1.95B |
| 242 | AGIO | Agios Pharmaceuticals, Inc. | 2.28B | 0.24% | 1,401,026 | 98.34M |
| 243 | PBH | Prestige Consumer Healthcare Inc. | 2.26B | 0.84% | 504,885 | 1.10B |
| 244 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | 1.45% | 1,002,679 | 959.90M |
| 245 | ADUS | Addus HomeCare Corporation | 2.24B | 0.78% | 312,143 | 1.48B |
| 246 | XNCR | Xencor, Inc. | 2.23B | - | 1,382,583 | 104.97M |
| 247 | VERA | Vera Therapeutics, Inc. | 2.23B | 3.17% | 1,277,484 | - |
| 248 | UFPT | UFP Technologies, Inc. | 2.22B | -3.00% | 71,128 | 631.64M |
| 249 | PRGO | Perrigo Company plc | 2.21B | -0.62% | 1,710,268 | 4.14B |
| 250 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.21B | 2.91% | 2,766,198 | 208.78M |
| 251 | PGEN | Precigen, Inc. | 2.18B | -1.14% | 3,673,414 | 85.72M |
| 252 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.14B | 3.33% | 3,937,459 | 940.61M |
| 253 | PGNY | Progyny, Inc. | 2.14B | 0.54% | 543,185 | 1.31B |
| 254 | IMNM | Immunome, Inc. | 2.13B | -0.05% | 952,129 | 4.02M |
| 255 | PVLA | Palvella Therapeutics, Inc. | 2.12B | 10.95% | 368,213 | - |
| 256 | VCEL | Vericel Corporation | 2.10B | -5.04% | 680,183 | 306.30M |
| 257 | SLS | SELLAS Life Sciences Group, Inc. | 2.10B | -14.71% | 23,771,723 | - |
| 258 | BFLY | Butterfly Network, Inc. | 2.08B | 5.83% | 5,601,434 | 112.14M |
| 259 | SEPN | Septerna, Inc. | 2.07B | 0.25% | 380,134 | 98.88M |
| 260 | ESTA | Establishment Labs Holdings Inc. | 2.06B | 3.02% | 790,788 | 245.82M |
| 261 | INSP | Inspire Medical Systems, Inc. | 2.05B | -0.46% | 367,094 | 898.74M |
| 262 | ZYME | Zymeworks Inc. | 2.05B | 0.17% | 833,140 | 37.13M |
| 263 | TRLV | Trulieve Cannabis Corp. | 2.05B | -0.47% | 1,096,646 | 1.14B |
| 264 | SRPT | Sarepta Therapeutics, Inc. | 2.04B | 2.28% | 1,377,530 | 1.97B |
| 265 | ABSI | Absci Corporation | 2.04B | 12.39% | 5,834,370 | 1.56M |
| 266 | LKFT | Lakefront Biotherapeutics NV | 2.04B | 0.82% | 268,988 | 1.13B |
| 267 | VIR | Vir Biotechnology, Inc. | 2.02B | 3.11% | 1,557,395 | 303.23M |
| 268 | ADRX | ADARx Pharmaceuticals, Inc. | 2.01B | -0.99% | 264,652 | 6.13M |
| 269 | GENB | Generate Biomedicines, Inc. | 1.97B | 16.43% | 3,939,995 | 26.48M |
| 270 | XERS | Xeris Biopharma Holdings, Inc. | 1.94B | 1.82% | 1,451,992 | 335.41M |
| 271 | WGS | GeneDx Holdings Corp. | 1.93B | 3.11% | 575,044 | 454.43M |
| 272 | TRVI | Trevi Therapeutics, Inc. | 1.93B | 1.27% | 1,065,879 | - |
| 273 | TRAX | First Tracks Biotherapeutics, Inc. | 1.92B | 0.75% | 640,962 | - |
| 274 | LMAT | LeMaitre Vascular, Inc. | 1.90B | -1.10% | 386,331 | 262.43M |
| 275 | MLYS | Mineralys Therapeutics, Inc. | 1.89B | 1.09% | 1,342,674 | - |
| 276 | XRAY | DENTSPLY SIRONA Inc. | 1.88B | 0.96% | 3,765,281 | 3.64B |
| 277 | ASTH | Astrana Health, Inc. | 1.88B | -0.73% | 253,463 | 3.84B |
| 278 | ZBIO | Zenas BioPharma, Inc. | 1.88B | 5.38% | 391,455 | 1.00M |
| 279 | NTLA | Intellia Therapeutics, Inc. | 1.87B | 8.47% | 4,860,350 | 59.51M |
| 280 | AMN | AMN Healthcare Services, Inc. | 1.81B | -0.19% | 1,011,394 | 3.43B |
| 281 | COAG | Hemab Therapeutics Holdings, Inc. | 1.80B | 0.26% | 414,023 | - |
| 282 | AZTA | Azenta, Inc. | 1.78B | 3.97% | 900,671 | 613.81M |
| 283 | KMTS | Kestra Medical Technologies, Ltd. | 1.78B | -0.40% | 538,409 | 106.73M |
| 284 | BRVE | Braveheart Bio, Inc. | 1.78B | -0.27% | 246,219 | - |
| 285 | ATEC | Alphatec Holdings, Inc. | 1.77B | 5.34% | 4,550,697 | 815.05M |
| 286 | ALVO | Alvotech | 1.76B | 4.00% | 627,901 | 494.61M |
| 287 | MAZE | Maze Therapeutics, Inc. | 1.76B | 0.13% | 385,586 | 20.00M |
| 288 | CERT | Certara, Inc. | 1.75B | 4.84% | 2,370,648 | 421.75M |
| 289 | KLRA | Kailera Therapeutics, Inc. | 1.74B | 2.21% | 877,060 | - |
| 290 | QURE | uniQure N.V. | 1.73B | 2.84% | 1,194,351 | 18.67M |
| 291 | NBTX | Nanobiotix S.A. | 1.72B | -1.59% | 65,835 | 13.15M |
| 292 | MESO | Mesoblast Limited | 1.72B | 1.59% | 173,214 | 120.25M |
| 293 | PSNL | Personalis, Inc. | 1.71B | 0.13% | 1,229,212 | 69.67M |
| 294 | STOK | Stoke Therapeutics, Inc. | 1.70B | 1.07% | 781,357 | 27.59M |
| 295 | NVAX | Novavax, Inc. | 1.70B | 2.99% | 4,687,274 | 413.80M |
| 296 | CMPS | COMPASS Pathways plc | 1.70B | 3.98% | 1,420,999 | - |
| 297 | ALHC | Alignment Healthcare, Inc. | 1.70B | 1.61% | 4,654,997 | 4.58B |
| 298 | RARE | Ultragenyx Pharmaceutical Inc. | 1.69B | 2.69% | 2,323,533 | 717.00M |
| 299 | ARDT | Ardent Health, Inc. | 1.68B | 0.85% | 377,463 | 6.41B |
| 300 | IMCR | Immunocore Holdings plc | 1.68B | 2.03% | 197,603 | 430.78M |
| 301 | NVCR | NovoCure Limited | 1.65B | -3.08% | 2,368,058 | 699.19M |
| 302 | URGN | UroGen Pharma Ltd. | 1.65B | -0.47% | 1,593,627 | 188.73M |
| 303 | OMCL | Omnicell, Inc. | 1.64B | -2.20% | 925,243 | 1.25B |
| 304 | HCSG | Healthcare Services Group, Inc. | 1.62B | -1.27% | 817,631 | 1.88B |
| 305 | NUVB | Nuvation Bio Inc. | 1.61B | 0.88% | 5,216,040 | 169.90M |
| 306 | OCUL | Ocular Therapeutix, Inc. | 1.60B | 8.48% | 2,842,491 | 52.06M |
| 307 | SNDA | Sonida Senior Living, Inc. | 1.59B | 2.44% | 511,545 | 481.07M |
| 308 | PAHC | Phibro Animal Health Corporation | 1.54B | -1.30% | 165,484 | 1.52B |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | 0.76% | 335,880 | 978.38M |
| 310 | GPCR | Structure Therapeutics Inc. | 1.53B | -0.32% | 987,392 | - |
| 311 | AGL | agilon health, inc. | 1.53B | 0.39% | 232,143 | 5.92B |
| 312 | INVA | Innoviva, Inc. | 1.53B | 0.86% | 585,271 | 440.00M |
| 313 | REPL | Replimune Group, Inc. | 1.51B | 23.07% | 7,284,662 | - |
| 314 | ANAB | AnaptysBio, Inc. | 1.51B | 1.75% | 309,812 | 106.09M |
| 315 | TYRA | Tyra Biosciences, Inc. | 1.50B | 1.07% | 354,803 | - |
| 316 | ETON | Eton Pharmaceuticals, Inc. | 1.48B | 1.25% | 339,615 | 105.60M |
| 317 | PNTG | The Pennant Group, Inc. | 1.47B | 1.18% | 332,581 | 1.10B |
| 318 | NUTX | Nutex Health Inc. | 1.46B | 2.10% | 119,469 | 846.72M |
| 319 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.03% | 913,998 | 746.16M |
| 320 | LYCA | Lycia Therapeutics, Inc. | 1.44B | -4.06% | 431,110 | 4.44M |
| 321 | FRNM | Freenome, Inc. | 1.44B | 3.07% | 495,778 | 35.41M |
| 322 | GHRS | GH Research PLC | 1.42B | 3.45% | 198,718 | - |
| 323 | TSHA | Taysha Gene Therapies, Inc. | 1.38B | -0.47% | 3,402,538 | 5.49M |
| 324 | KRSA | Korsana Biosciences, Inc. | 1.37B | 0.13% | 118,326 | - |
| 325 | CNMD | CONMED Corporation | 1.37B | -3.05% | 610,179 | 1.37B |
| 326 | TNDM | Tandem Diabetes Care, Inc. | 1.37B | 2.39% | 2,137,718 | 1.04B |
| 327 | AAPG | Ascentage Pharma Group International | 1.35B | 0.91% | 4,714 | 94.61M |
| 328 | DMRA | Damora Therapeutics, Inc. | 1.33B | -1.59% | 341,763 | - |
| 329 | NKTR | Nektar Therapeutics | 1.32B | 1.53% | 403,651 | 54.59M |
| 330 | OMER | Omeros Corporation | 1.29B | 2.23% | 599,450 | 38.42M |
| 331 | LBRX | LB Pharmaceuticals Inc | 1.28B | 0.48% | 201,736 | - |
| 332 | KARD | Kardigan, Inc. | 1.28B | 0.96% | 469,173 | - |
| 333 | SNDX | Syndax Pharmaceuticals, Inc. | 1.28B | 4.60% | 2,745,900 | 252.25M |
| 334 | SVRA | Savara Inc. | 1.28B | 3.29% | 1,786,662 | - |
| 335 | USPH | U.S. Physical Therapy, Inc. | 1.27B | -2.31% | 187,289 | 804.27M |
| 336 | ENOV | Enovis Corporation | 1.26B | 1.72% | 1,176,248 | 2.30B |
| 337 | TDOC | Teladoc Health, Inc. | 1.25B | 6.67% | 8,643,055 | 2.47B |
| 338 | INNV | InnovAge Holding Corp. | 1.24B | -0.22% | 475,986 | 989.71M |
| 339 | CRON | Cronos Group Inc. | 1.24B | -0.89% | 536,108 | 179.09M |
| 340 | STAA | STAAR Surgical Company | 1.23B | 1.86% | 675,331 | 339.59M |
| 341 | DRTS | Alpha Tau Medical Ltd. | 1.23B | -1.18% | 401,163 | - |
| 342 | BVS | Bioventus Inc. | 1.23B | 1.60% | 590,107 | 581.85M |
| 343 | VOR | Vor Biopharma Inc. | 1.22B | 5.68% | 1,013,804 | - |
| 344 | OPK | OPKO Health, Inc. | 1.21B | 0.62% | 2,527,568 | 587.90M |
| 345 | VSTM | Verastem, Inc. | 1.19B | -2.62% | 2,808,943 | 87.53M |
| 346 | SLN | Silence Therapeutics plc | 1.19B | -0.35% | 2,757,525 | 615.00K |
| 347 | GDRX | GoodRx Holdings, Inc. | 1.18B | -0.29% | 765,365 | 785.23M |
| 348 | OMDA | Omada Health, Inc. | 1.17B | 0.89% | 556,325 | 309.76M |
| 349 | PRCT | PROCEPT BioRobotics Corporation | 1.16B | 2.02% | 904,691 | 337.34M |
| 350 | AVLN | Avalyn Pharma Inc. | 1.14B | -0.35% | 1,085,546 | - |
| 351 | CSTL | Castle Biosciences, Inc. | 1.12B | 6.29% | 431,159 | 357.28M |
| 352 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.12B | 2.97% | 397,259 | 730.02M |
| 353 | AORT | Artivion, Inc. | 1.12B | -0.09% | 421,649 | 471.47M |
| 354 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | -0.43% | 209,986 | 1.04B |
| 355 | AHG | Akso Health Group | 1.11B | -7.80% | 106,827 | 13.83M |
| 356 | JANX | Janux Therapeutics, Inc. | 1.10B | 4.58% | 984,103 | 24.00M |
| 357 | MNKD | MannKind Corporation | 1.10B | 4.26% | 3,049,855 | 393.63M |
| 358 | HROW | Harrow, Inc. | 1.10B | 1.10% | 327,282 | 275.59M |
| 359 | SGP | SpyGlass Pharma, Inc. | 1.10B | 6.34% | 211,716 | - |
| 360 | SPTX | Seaport Therapeutics, Inc. | 1.09B | -4.23% | 355,270 | - |
| 361 | RAPP | Rapport Therapeutics, Inc. | 1.08B | -18.30% | 5,960,886 | 20.00M |
| 362 | INBX | Inhibrx Biosciences, Inc. | 1.08B | -23.38% | 1,186,389 | 1.30M |
| 363 | CTY | City Therapeutics, Inc. | 1.08B | 3.79% | 335,293 | 14.34M |
| 364 | IRMD | IRADIMED CORPORATION | 1.07B | -0.02% | 161,626 | 86.34M |
| 365 | LTGO | Latigo Biotherapeutics, Inc. | 1.05B | 4.08% | 186,550 | - |
| 366 | MLTX | MoonLake Immunotherapeutics | 1.05B | 3.19% | 1,185,048 | - |
| 367 | CBLL | CeriBell, Inc. | 1.04B | - | 742,942 | 101.96M |
| 368 | HSTM | HealthStream, Inc. | 1.03B | -1.32% | 176,285 | 321.12M |
| 369 | IMTX | Immatics N.V. | 1.00B | 1.24% | 1,765,475 | 47.65M |
| 370 | CGEM | Cullinan Therapeutics, Inc. | 1.00B | 4.85% | 594,218 | - |
| 371 | SIBN | SI-BONE, Inc. | 978.39M | 1.82% | 452,491 | 213.60M |
| 372 | BBNX | Beta Bionics, Inc. | 970.45M | -16.55% | 2,798,437 | 127.27M |
| 373 | ORIC | ORIC Pharmaceuticals, Inc. | 963.97M | 3.33% | 1,401,793 | - |
| 374 | QDEL | QuidelOrtho Corporation | 960.74M | 3.09% | 1,619,452 | 2.67B |
| 375 | KURA | Kura Oncology, Inc. | 953.66M | 8.28% | 2,288,909 | 77.23M |
| 376 | PRME | Prime Medicine, Inc. | 953.57M | 23.22% | 15,198,382 | 4.07M |
| 377 | IART | Integra LifeSciences Holdings Corporation | 952.28M | 2.09% | 1,789,005 | 1.66B |
| 378 | RIGL | Rigel Pharmaceuticals, Inc. | 947.82M | 0.38% | 226,309 | 276.79M |
| 379 | MGTX | MeiraGTx Holdings plc | 936.42M | 3.72% | 628,272 | 397.50M |
| 380 | ODTX | Odyssey Therapeutics, Inc. | 936.33M | 0.21% | 209,696 | 99.00K |
| 381 | AKTS | Aktis Oncology, Inc. | 935.52M | 2.25% | 193,112 | 10.06M |
| 382 | JBIO | Jade Biosciences, Inc. | 927.89M | -1.02% | 671,339 | - |
| 383 | GLUE | Monte Rosa Therapeutics, Inc. | 925.65M | 1.78% | 1,625,140 | 28.73M |
| 384 | ALMS | Alumis Inc. | 922.87M | 7.38% | 2,431,964 | 7.40M |
| 385 | ANRO | Alto Neuroscience, Inc. | 915.52M | 0.60% | 300,195 | - |
| 386 | OBX | Obsidian Therapeutics, Inc. | 901.27M | 2.39% | 410,417 | - |
| 387 | DNA | Ginkgo Bioworks Holdings, Inc. | 896.97M | 18.19% | 3,776,589 | 132.42M |
| 388 | CRVS | Corvus Pharmaceuticals, Inc. | 884.95M | -0.19% | 911,663 | - |
| 389 | PACB | Pacific Biosciences of California, Inc. | 879.65M | 15.51% | 34,832,739 | 159.27M |
| 390 | IVA | Inventiva S.A. | 869.06M | 0.68% | 946,889 | 2.81M |
| 391 | PHAR | Pharming Group N.V. | 858.69M | 3.29% | 29,024 | 386.75M |
| 392 | ABUS | Arbutus Biopharma Corporation | 854.70M | 0.70% | 1,342,721 | 181.72M |
| 393 | GMRS | GMR Solutions Inc. | 848.72M | 2.44% | 324,752 | 5.88B |
| 394 | AHCO | AdaptHealth Corp. | 804.46M | 3.08% | 1,558,273 | 3.36B |
| 395 | KIDS | OrthoPediatrics Corp. | 804.35M | 29.30% | 1,794,509 | 264.14M |
| 396 | CTKB | Cytek Biosciences, Inc. | 798.10M | 2.68% | 1,597,841 | 206.71M |
| 397 | APMD | Apnimed, Inc. | 797.23M | -1.74% | 323,307 | 115.12M |
| 398 | HELP | Helus Pharma Inc. | 797.09M | 3.71% | 664,528 | - |
| 399 | SANA | Sana Biotechnology, Inc. | 787.32M | 6.48% | 3,287,485 | - |
| 400 | VREX | Varex Imaging Corporation | 777.63M | -0.05% | 543,563 | 865.00M |
| 401 | AVBP | ArriVent BioPharma, Inc. | 775.61M | 2.14% | 989,991 | - |
| 402 | ARDX | Ardelyx, Inc. | 772.48M | 3.33% | 3,941,465 | 450.89M |
| 403 | INMD | InMode Ltd. | 768.52M | -1.55% | 536,867 | 374.63M |
| 404 | PHR | Phreesia, Inc. | 767.82M | 0.65% | 622,216 | 507.79M |
| 405 | OABI | OmniAb, Inc. | 767.66M | 6.45% | 1,576,509 | 38.46M |
| 406 | ANNX | Annexon, Inc. | 765.90M | 7.45% | 4,011,589 | - |
| 407 | SGMT | Sagimet Biosciences Inc. | 761.56M | 3.07% | 1,235,562 | - |
| 408 | COLL | Collegium Pharmaceutical, Inc. | 756.27M | 1.00% | 406,091 | 808.21M |
| 409 | GYRE | Gyre Therapeutics, Inc. | 751.78M | 8.58% | 125,144 | 109.82M |
| 410 | ATTO | Attovia Therapeutics, Inc. | 721.29M | 5.33% | 174,511 | 1.80M |
| 411 | WVE | Wave Life Sciences, Inc. | 717.91M | 5.51% | 4,263,440 | 70.92M |
| 412 | FDMT | 4D Molecular Therapeutics, Inc. | 714.31M | 8.11% | 1,189,747 | 92.01M |
| 413 | ACHV | Achieve Life Sciences, Inc. | 704.88M | -1.15% | 966,162 | - |
| 414 | IAM | Iambic Therapeutics, Inc. | 700.58M | 5.57% | 926,308 | 18.25M |
| 415 | SLDB | Solid Biosciences Inc. | 694.82M | 4.68% | 1,510,796 | - |
| 416 | DSGN | Design Therapeutics, Inc. | 693.40M | 4.23% | 522,012 | - |
| 417 | SLBT | SL Science Holding Limited | 690.02M | -1.63% | 18,996 | 3.27M |
| 418 | STLN | Starling Oncology, Inc. | 676.72M | 0.76% | 1,152,637 | 587.24M |
| 419 | IMMX | Immix Biopharma, Inc. | 673.59M | 0.93% | 1,235,019 | - |
| 420 | SOPH | SOPHiA GENETICS SA | 669.96M | 4.38% | 285,135 | 86.17M |
| 421 | AURA | Aura Biosciences, Inc. | 663.71M | 1.59% | 541,714 | - |
| 422 | CADL | Candel Therapeutics, Inc. | 663.42M | 5.09% | 663,704 | - |
| 423 | LXRX | Lexicon Pharmaceuticals, Inc. | 660.76M | 0.34% | 1,613,109 | 41.47M |
| 424 | ANL | Adlai Nortye Group Ltd. | 656.86M | -4.76% | 125,324 | 18.06M |
| 425 | OLMA | Olema Pharmaceuticals, Inc. | 655.36M | 6.39% | 1,436,491 | - |
| 426 | BCAX | Bicara Therapeutics Inc. | 645.85M | -44.16% | 15,424,695 | - |
| 427 | CRMD | CorMedix Inc. | 639.14M | 2.50% | 1,158,417 | 462.25M |
| 428 | MYGN | Myriad Genetics, Inc. | 634.16M | 5.41% | 2,493,254 | 806.60M |
| 429 | DBVT | DBV Technologies S.A. | 628.64M | 5.13% | 225,613 | 5.04M |
| 430 | GERN | Geron Corporation | 622.24M | -15.78% | 81,724,665 | 204.56M |
| 431 | ACRS | Aclaris Therapeutics, Inc. | 613.74M | 4.49% | 3,878,620 | 8.22M |
| 432 | ZVRA | Zevra Therapeutics, Inc. | 612.25M | 2.49% | 975,962 | 136.07M |
| 433 | NGNE | Neurogene Inc. | 608.75M | 12.71% | 635,697 | 925.00K |
| 434 | NVCT | Nuvectis Pharma, Inc. | 598.20M | -0.43% | 191,962 | - |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 596.52M | 2.85% | 1,410,582 | 389.32M |
| 436 | AVR | Anteris Technologies Global Corp. | 594.71M | 1.67% | 1,542,703 | 2.24M |
| 437 | FLGT | Fulgent Genetics, Inc. | 592.13M | 3.96% | 397,561 | 323.93M |
| 438 | EVO | Evotec SE | 588.40M | 2.23% | 145,663 | 819.47M |
| 439 | STTK | Shattuck Labs, Inc. | 582.61M | 0.61% | 799,275 | 1.00M |
| 440 | CLYM | Climb Bio, Inc. | 581.25M | 5.75% | 945,709 | - |
| 441 | CBIO | Crescent Biopharma, Inc. | 577.81M | 1.73% | 238,735 | 11.88M |
| 442 | MDXG | MiMedx Group, Inc. | 575.75M | 1.28% | 1,255,753 | 303.73M |
| 443 | ETRA | Electra Therapeutics, Inc. | 563.65M | 5.40% | 177,304 | - |
| 444 | PBYI | Puma Biotechnology, Inc. | 548.21M | -2.75% | 416,871 | 231.24M |
| 445 | DRUG | Bright Minds Biosciences Inc. | 546.50M | 2.41% | 71,094 | - |
| 446 | TCMD | Tactile Systems Technology, Inc. | 541.62M | 1.92% | 140,096 | 350.31M |
| 447 | VALN | Valneva SE | 541.12M | 3.05% | 3,855 | 163.30M |
| 448 | ENTX | Entera Bio Ltd. | 539.16M | 1.31% | 181,559 | 42.00K |
| 449 | MASS | 908 Devices Inc. | 531.96M | 4.13% | 295,749 | 60.84M |
| 450 | SRZN | Surrozen, Inc. | 530.98M | 2.78% | 142,656 | 11.51M |
| 451 | AQST | Aquestive Therapeutics, Inc. | 530.91M | 3.93% | 1,551,655 | 54.09M |
| 452 | DMAC | DiaMedica Therapeutics Inc. | 529.55M | 13.00% | 521,278 | - |
| 453 | BLSM | BlossomHill Therapeutics, Inc. | 523.18M | 4.44% | 72,376 | - |
| 454 | DCTH | Delcath Systems, Inc. | 515.62M | 0.75% | 315,202 | 95.42M |
| 455 | CTMX | CytomX Therapeutics, Inc. | 514.24M | 2.16% | 4,080,317 | 18.30M |
| 456 | INDP | Indaptus Therapeutics, Inc. | 511.43M | 0.76% | 213,433 | - |
| 457 | RCEL | AVITA Medical, Inc. | 510.29M | 2.61% | 458,974 | 75.63M |
| 458 | ANGO | AngioDynamics, Inc. | 510.12M | -1.06% | 570,945 | 325.38M |
| 459 | SGHT | Sight Sciences, Inc. | 509.01M | 2.33% | 346,162 | 83.38M |
| 460 | EOLS | Evolus, Inc. | 504.30M | 3.60% | 671,393 | 316.49M |
| 461 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 462 | PHAT | Phathom Pharmaceuticals, Inc. | 498.82M | 4.84% | 2,082,824 | 239.66M |
| 463 | NRC | NRC Health | 498.07M | 7.91% | 242,154 | 143.79M |
| 464 | ARVN | Arvinas, Inc. | 496.94M | 2.01% | 891,608 | 316.70M |
| 465 | FTH | Faeth Therapeutics, Inc. | 496.14M | 0.47% | 418,076 | - |
| 466 | SENS | Senseonics Holdings, Inc. | 493.84M | 12.12% | 998,828 | 48.55M |
| 467 | OCS | Oculis Holding AG | 492.62M | 1.92% | 218,103 | 1.45M |
| 468 | MNPR | Monopar Therapeutics Inc. | 492.61M | 2.16% | 186,898 | - |
| 469 | EVH | Evolent Health, Inc. | 489.55M | -2.04% | 2,148,310 | 2.10B |
| 470 | SSII | SS Innovations International, Inc. | 488.94M | -2.40% | 13,484 | 52.40M |
| 471 | CERS | Cerus Corporation | 487.69M | 0.83% | 1,456,181 | 221.55M |
| 472 | TKNO | Alpha Teknova, Inc. | 484.98M | 10.55% | 951,607 | 43.70M |
| 473 | EPRX | Eupraxia Pharmaceuticals Inc. | 482.73M | 4.24% | 419,990 | - |
| 474 | OVID | Ovid Therapeutics Inc. | 478.48M | 8.41% | 2,048,161 | 1.58M |
| 475 | RGNX | REGENXBIO Inc. | 477.94M | 9.70% | 2,000,379 | 174.48M |
| 476 | PRTA | Prothena Corporation plc | 467.17M | 3.29% | 751,917 | 54.53M |
| 477 | PROK | ProKidney Corp. | 459.53M | 0.33% | 1,497,807 | 818.00K |
| 478 | BWAY | BrainsWay Ltd. | 454.21M | -2.24% | 89,435 | 60.70M |
| 479 | EDIT | Editas Medicine, Inc. | 453.06M | 13.46% | 4,430,048 | 47.01M |
| 480 | KMDA | Kamada Ltd. | 452.79M | -0.62% | 70,191 | 191.85M |
| 481 | ALLO | Allogene Therapeutics, Inc. | 449.14M | 5.69% | 10,323,326 | 4.64M |
| 482 | YDES | YD Bio Limited | 444.82M | 3.97% | 283,872 | 1.24M |
| 483 | NPCE | NeuroPace, Inc. | 443.81M | -0.69% | 188,387 | 106.99M |
| 484 | MPLT | MapLight Therapeutics, Inc. | 443.49M | -2.33% | 362,495 | - |
| 485 | RZLT | Rezolute, Inc. | 442.66M | 2.68% | 1,414,466 | - |
| 486 | AUTL | Autolus Therapeutics plc | 433.84M | 5.16% | 1,394,965 | 117.39M |
| 487 | PRLD | Prelude Therapeutics Incorporated | 426.40M | 6.70% | 475,868 | 22.42M |
| 488 | SRTA | Strata Critical Medical, Inc. | 421.10M | 0.85% | 950,584 | 255.98M |
| 489 | ZURA | Zura Bio Limited | 419.02M | 1.87% | 4,390,813 | - |
| 490 | ASMB | Assembly Biosciences, Inc. | 418.82M | 1.33% | 142,684 | 74.85M |
| 491 | CARL | Carlsmed, Inc. | 418.00M | -0.71% | 148,155 | 63.30M |
| 492 | CCCC | C4 Therapeutics, Inc. | 417.67M | 5.76% | 4,110,702 | 35.04M |
| 493 | OFIX | Orthofix Medical Inc. | 408.96M | 3.40% | 290,140 | 833.19M |
| 494 | NAUT | Nautilus Biotechnology, Inc. | 408.87M | 11.07% | 15,062,396 | 424.00K |
| 495 | ALT | Altimmune, Inc. | 408.49M | 2.94% | 4,332,412 | 31.00K |
| 496 | SI | Shoulder Innovations, Inc. | 405.55M | 0.72% | 55,938 | 60.06M |
| 497 | TECX | Tectonic Therapeutic, Inc. | 401.93M | 1.08% | 215,885 | - |
| 498 | TLRY | Tilray Brands, Inc. | 394.52M | -2.89% | 7,277,566 | 963.10M |
| 499 | MOBI | Mobia Medical, Inc. | 392.50M | 5.83% | 292,678 | 45.28M |
| 500 | AGMB | AgomAb Therapeutics NV | 392.01M | -5.24% | 105,604 | - |